HPV
status
cervical
lymph
node
metastases
correctly
classified
using
HC-2
assay
84
%
(
21/25
)
cases
.

Accuracy
improved
100
%
cytologic
evaluation
confirmed
presence
cancer
cells
test
samples
.

The
estimated
cost
savings
CMS
using
HC-2
assay
ranged
$
113.74
$
364.63
per
patient
.

